Ascorbic Acid Levels in MDS, AML, and CMML Patients

Completed

Conditions studied: Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS, AML, CMML

In brief

This study is a non-interventional, specimen collection translational study to evaluate vitamin C levels in the peripheral blood of Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia (CMML) patients.

Key facts

Study ID

NCT03526666

Run by

Van Andel Research Institute

People needed

50

Starts

2017-11-01

Expected to finish

2018-10-31

Last updated by the study team

2019-10-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients actively receiving treatment for acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML).
• Patients diagnosed with AML, MDS, or CMML and are treatment naïve.
• Patients who are 18 years old or older.

You may not qualify if…

• Patients deemed as too ill to participate as determined by the clinical investigator.
• Non-English speaking patients
• Patients unable to provide informed consent.

Where it is running

• Cancer and Hematology Centers of Western Michigan — Grand Rapids, Michigan, United States
• Metro Health - University of Michigan Health — Wyoming, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.